NB
MRNA icon

Norinchukin Bank’s Moderna MRNA Stock Holding History

Norinchukin Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Sell
21,383
-204
-0.9% -$10.6K 0.01% 385
2026
Q1 		$1.1M Buy
21,587
+47
+0.2% +$2.19K 0.01% 425
2025
Q4 		$635K Buy
21,540
+1,868
+9% +$50.8K 0.01% 499
2025
Q3 		$508K Buy
19,672
+1,003
+5% +$28K 0.01% 510
2025
Q2 		$515K Buy
18,669
+2,004
+12% +$52.8K 0.01% 506
2025
Q1 		$472K Buy
16,665
+2,103
+14% +$74.6K 0.01% 498
2024
Q4 		$605K Sell
14,562
-2,457
-14% -$117K 0.01% 454
2024
Q3 		$1.14M Buy
17,019
+2,356
+16% +$216K 0.03% 323
2024
Q2 		$1.74M Buy
14,663
+623
+4% +$78.8K 0.05% 204
2024
Q1 		$1.5M Sell
14,040
-282
-2% -$28.4K 0.04% 237
2023
Q4 		$1.42M Sell
14,322
-1,086
-7% -$91.3K 0.03% 237
2023
Q3 		$1.59M Sell
15,408
-4,377
-22% -$488K 0.04% 221
2023
Q2 		$2.4M Sell
19,785
-4,954
-20% -$661K 0.04% 277
2023
Q1 		$3.8M Buy
24,739
+678
+3% +$112K 0.07% 158
2022
Q4 		$4.32M Sell
24,061
-4,364
-15% -$714K 0.09% 138
2022
Q3 		$3.36M Buy
28,425
+1,506
+6% +$229K 0.07% 173
2022
Q2 		$3.85M Sell
26,919
-9,524
-26% -$1.36M 0.08% 154
2022
Q1 		$6.28M Buy
36,443
+3,697
+11% +$622K 0.08% 138
2021
Q4 		$8.32M Sell
32,746
-2,128
-6% -$622K 0.1% 114
2021
Q3 		$13.4M Buy
34,874
+30,260
+656% +$11.2M 0.19% 86
2021
Q2 		$1.08M Buy
4,614
+710
+18% +$127K 0.02% 417
2021
Q1 		$511K Buy
3,904
+1,223
+46% +$177K 0.01% 490
2020
Q4 		$280K Buy
+2,681
New +$271K ﹤0.01% 509

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Norinchukin Bank's MRNA Position: Q2 2026 in Review

Norinchukin Bank reduced its Moderna (MRNA) stake by 0.95% in Q2 2026, selling an estimated $10.6K and leaving 21,383 shares worth $1.5M. The position accounts for 0.01% of the portfolio, ranked #385.

Norinchukin Bank first reported a position in MRNA in Q4 2020 and has held it in 23 quarters since. The position peaked at $13.4M in Q3 2021. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Norinchukin Bank held 21,383 shares of Moderna worth $1.5M as of Q2 2026.
  • Norinchukin Bank sold 204 Moderna shares in Q2 2026, an estimated $10.6K.
  • Moderna made up 0.01% of Norinchukin Bank's portfolio in Q2 2026, its #385 holding.
  • Norinchukin Bank first reported a position in Moderna in Q4 2020 and has held it in 23 quarters since.
  • Norinchukin Bank's Moderna position peaked at $13.4M in Q3 2021.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Norinchukin Bank's 13F filing for Q2 2026, filed 14 Aug 2026.